Pulmonx Corp Income Before Tax Over Time
| LUNG Stock | USD 6.30 0.16 2.48% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pulmonx Corp Performance and Pulmonx Corp Correlation. Pulmonx |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Before Tax Analysis
Compare Pulmonx Corp and related stocks such as Iradimed, Orthofix Medical, and Neuropace Income Before Tax Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRMD | 1.4 M | 1.4 M | 1.4 M | 2.8 M | 3 M | 11.6 M | 11 M | 1.4 M | 6.2 M | 9 M | (616.9 K) | 9.8 M | 16.2 M | 21.7 M | 22.8 M |
| OFIX | 7.5 M | 20.7 M | 82.7 M | (6.5 M) | 12.5 M | 8.5 M | 19 M | 36.4 M | 22.9 M | (27 M) | (368 K) | (13.5 M) | (17.7 M) | (148.7 M) | (141.2 M) |
| NPCE | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (24.3 M) | (36.1 M) | (47.1 M) | (33 M) | (34.6 M) |
| ITGR | (2.3 M) | 48.4 M | 6.7 M | 48.8 M | 76.6 M | (15.7 M) | 1.2 M | 21.8 M | 61.1 M | 105.2 M | 86.2 M | 101.1 M | 76 M | 107.3 M | 112.7 M |
| CNMD | 1.2 M | (2.3 M) | 59.5 M | 50.6 M | 46.7 M | 45.1 M | 19.4 M | 28.7 M | 50.7 M | 31.2 M | 1.6 M | 73.1 M | (70.9 M) | 80.8 M | 84.9 M |
| KIDS | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (12.7 M) | (33.7 M) | (17.4 M) | (3.7 M) | (21.3 M) | (22.4 M) |
| SIBN | (10.9 M) | (10.9 M) | (10.9 M) | (6.1 M) | (27.8 M) | (28.2 M) | (20.6 M) | (23 M) | (17.5 M) | (38.4 M) | (43.7 M) | (56.6 M) | (61.3 M) | (43.3 M) | (45.5 M) |
| RXST | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 27.6 M | (48.7 M) | (66.7 M) | (48.6 M) | (46.2 M) |
| AXGN | 700 K | (6.9 M) | (10.2 M) | (14.6 M) | (17.7 M) | (13.4 M) | (14.4 M) | (10.4 M) | (22.4 M) | (29.1 M) | (23.8 M) | (27 M) | (28.9 M) | (21.7 M) | (20.6 M) |
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (47.1 M) |
| LIVN | (5.1 M) | 60.4 M | 75.3 M | 79.9 M | 89.3 M | (39.3 M) | (33 M) | 121.1 M | (247.4 M) | (185.7 M) | (344 M) | (124.5 M) | (75.1 M) | (81.2 M) | (77.2 M) |
| ELMD | (142.7 K) | 437.6 K | (1.9 M) | (819.6 K) | 1.2 M | 3 M | 3.5 M | 3 M | 2.9 M | 5.2 M | 3.2 M | 3 M | 4.1 M | 7 M | 7.4 M |
| SRDX | 1.7 M | 16.3 M | 20.4 M | 18.5 M | 19.7 M | 16.9 M | 7 M | (7.5 M) | 7.6 M | (1.5 M) | 6.3 M | (22.5 M) | 2.5 M | (7.5 M) | (7.1 M) |
| INGN | (2 M) | (2 M) | 582 K | 3.8 M | 10.1 M | 14.7 M | 22.7 M | 29.7 M | 40.5 M | 24.3 M | (5.3 M) | 8.7 M | (83.3 M) | (102.3 M) | (97.2 M) |
| APYX | (154.1 K) | 32 K | 834 K | (6 M) | (13.3 M) | (5.3 M) | (3.9 M) | (5.2 M) | (13.3 M) | (19.9 M) | (19.4 M) | (14.8 M) | (22.9 M) | (21.3 M) | (20.2 M) |
Pulmonx Corp and related stocks such as Iradimed, Orthofix Medical, and Neuropace Income Before Tax description
Income Before Tax which can also be referred as pre-tax income is reported on Pulmonx Corp income statement and is an important metric when analyzing Pulmonx Corp profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.My Equities
My Current Equities and Potential Positions
| Pulmonx Corp | LUNG |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 6.3
Check out Pulmonx Corp Performance and Pulmonx Corp Correlation. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Pulmonx Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.